These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 10639181)

  • 1. Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: facile conversion of nonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitors.
    Kalgutkar AS; Crews BC; Rowlinson SW; Marnett AB; Kozak KR; Remmel RP; Marnett LJ
    Proc Natl Acad Sci U S A; 2000 Jan; 97(2):925-30. PubMed ID: 10639181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ester and amide derivatives of the nonsteroidal antiinflammatory drug, indomethacin, as selective cyclooxygenase-2 inhibitors.
    Kalgutkar AS; Marnett AB; Crews BC; Remmel RP; Marnett LJ
    J Med Chem; 2000 Jul; 43(15):2860-70. PubMed ID: 10956194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amide derivatives of meclofenamic acid as selective cyclooxygenase-2 inhibitors.
    Kalgutkar AS; Rowlinson SW; Crews BC; Marnett LJ
    Bioorg Med Chem Lett; 2002 Feb; 12(4):521-4. PubMed ID: 11844663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction of arginine 106 of human prostaglandin G/H synthase-2 with inhibitors is not a universal component of inhibition mediated by nonsteroidal anti-inflammatory drugs.
    Greig GM; Francis DA; Falgueyret JP; Ouellet M; Percival MD; Roy P; Bayly C; Mancini JA; O'Neill GP
    Mol Pharmacol; 1997 Nov; 52(5):829-38. PubMed ID: 9351974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoform-selective interaction of cyclooxygenase-2 with indomethacin amides studied by real-time fluorescence, inhibition kinetics, and site-directed mutagenesis.
    Timofeevski SL; Prusakiewicz JJ; Rouzer CA; Marnett LJ
    Biochemistry; 2002 Jul; 41(30):9654-62. PubMed ID: 12135387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 1. Thiazolone and oxazolone series.
    Song Y; Connor DT; Doubleday R; Sorenson RJ; Sercel AD; Unangst PC; Roth BD; Gilbertsen RB; Chan K; Schrier DJ; Guglietta A; Bornemeier DA; Dyer RD
    J Med Chem; 1999 Apr; 42(7):1151-60. PubMed ID: 10197959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of selective inhibitors of cyclooxygenase-2 as nonulcerogenic anti-inflammatory agents.
    Marnett LJ; Kalgutkar AS
    Curr Opin Chem Biol; 1998 Aug; 2(4):482-90. PubMed ID: 9736921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Covalent modification of cyclooxygenase-2 (COX-2) by 2-acetoxyphenyl alkyl sulfides, a new class of selective COX-2 inactivators.
    Kalgutkar AS; Kozak KR; Crews BC; Hochgesang GP; Marnett LJ
    J Med Chem; 1998 Nov; 41(24):4800-18. PubMed ID: 9822550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 2. 1,3,4- and 1,2,4-thiadiazole series.
    Song Y; Connor DT; Sercel AD; Sorenson RJ; Doubleday R; Unangst PC; Roth BD; Beylin VG; Gilbertsen RB; Chan K; Schrier DJ; Guglietta A; Bornemeier DA; Dyer RD
    J Med Chem; 1999 Apr; 42(7):1161-9. PubMed ID: 10197960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays.
    Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J
    Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indolyl esters and amides related to indomethacin are selective COX-2 inhibitors.
    Kalgutkar AS; Crews BC; Saleh S; Prudhomme D; Marnett LJ
    Bioorg Med Chem; 2005 Dec; 13(24):6810-22. PubMed ID: 16169736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of a selective cyclooxygenase-2 inhibitor, HN-56249: a novel compound exhibiting a marked preference for the human enzyme in intact cells.
    Berg J; Fellier H; Christoph T; Kremminger P; Hartmann M; Blaschke H; Rovensky F; Towart R; Stimmeder D
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):363-72. PubMed ID: 10763850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal antiinflammatory drugs on mucosal ulcerogenic and healing responses of the stomach.
    Ukawa H; Yamakuni H; Kato S; Takeuchi K
    Dig Dis Sci; 1998 Sep; 43(9):2003-11. PubMed ID: 9753266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonsteroidal antiinflammatory drugs inhibit cyclooxygenase-2 enzyme activity but not mRNA expression in human macrophages.
    Barrios-Rodiles M; Keller K; Belley A; Chadee K
    Biochem Biophys Res Commun; 1996 Aug; 225(3):896-900. PubMed ID: 8780708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors.
    Gierse JK; McDonald JJ; Hauser SD; Rangwala SH; Koboldt CM; Seibert K
    J Biol Chem; 1996 Jun; 271(26):15810-4. PubMed ID: 8663121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From indomethacin to a selective COX-2 inhibitor. Development of indolalkanoic acids as potent and selective cyclooxygenase-2 inhibitors.
    Lau CK; Black WC; Belley M; Chan C; Charleson S; Denis D; Gauthier JY; Gordon R; Guay D; Hamel P; Kargman S; Leblanc Y; Mancini J; Ouellet M; Percival D; Prasit P; Roy P; Skorey K; Tagari P; Vickers P; Wong E
    Adv Exp Med Biol; 1997; 407():73-8. PubMed ID: 9321934
    [No Abstract]   [Full Text] [Related]  

  • 18. Determination of expression of cyclooxygenase-1 and -2 isozymes in canine tissues and their differential sensitivity to nonsteroidal anti-inflammatory drugs.
    Wilson JE; Chandrasekharan NV; Westover KD; Eager KB; Simmons DL
    Am J Vet Res; 2004 Jun; 65(6):810-8. PubMed ID: 15198222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial.
    Swan SK; Rudy DW; Lasseter KC; Ryan CF; Buechel KL; Lambrecht LJ; Pinto MB; Dilzer SC; Obrda O; Sundblad KJ; Gumbs CP; Ebel DL; Quan H; Larson PJ; Schwartz JI; Musliner TA; Gertz BJ; Brater DC; Yao SL
    Ann Intern Med; 2000 Jul; 133(1):1-9. PubMed ID: 10877734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential inhibition of murine prostaglandin synthase-1 and -2 by nonsteroidal anti-inflammatory drugs using exogenous and endogenous sources of arachidonic acid.
    Chulada PC; Langenbach R
    J Pharmacol Exp Ther; 1997 Feb; 280(2):606-13. PubMed ID: 9023270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.